TITLE

Toward Office-Based Measurement of Gastric Emptying in Symptomatic Diabetics Using [13C]Octanoic Acid Breath Test

AUTHOR(S)
Joon Seong Lee; Camilleri, Michael; Zinsmeister, Alan R.; Burton, Duane D.; Myung-Gyu Choi; Nair, K. Sreekumaran; Verlinden, Marleen
PUB. DATE
October 2000
SOURCE
American Journal of Gastroenterology;Oct2000, Vol. 95 Issue 10, p2751
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: Current methods for measuring gastric emptying by breath test require sampling over several hours and are too inaccurate for clinical use. The aim of this study was to develop an office-based method for measuring gastric emptying of solids in patients with diabetes using a [13C]oclanoic acid breath test. METHODS: In 22 symptomatic diabetic patients (17 insulin-dependent diabetes, 5 non-insulin-dependent diabetes) and 6 controls, we simultaneously measured gastric emptying of an egg meal (420 kcal) by scintigraphy and [13C]octanoic acid breath test. Conventional (nonlinear) methods for scintigraphic and [13C]octanoic acid breath test emptying and generalized linear regression method to predict scintigraphic half-life (1½) using four breath samples obtained during the first 3 h. RESULTS: Despite 8 h of breath sampling, the t½ estimate using the conventional method was markedly different from the scintigraphic value (Δt½ median, 113 min; range, 19-282 min). The generalized linear model (using samples at baseline, 30, and 120 or 150 min) yielded predicted scintigraphic tLAG and t½ that were more accurate than the conventional method; mean standard deviations of differences were 16 and 27 min, respectively. Breath test correctly assessed normal or prolonged emptying in 21 of 22 patients. CONCLUSIONS: The [13C]octanoic acid breath test can be simplified to measure gastric tLAG and t½ and can be expected to correctly identify normal t½ in symptomatic diabetics. Further refinement of the model will need to include studies of patients with markedly delayed t½.
ACCESSION #
17623946

 

Related Articles

  • Researchers develop diabetes breathalyzer.  // Medical Device Daily;6/14/2013, Vol. 17 Issue 115, p1 

    The article focuses on the sensor technology created by the University of Pittsburgh chemists that could significantly simplify the diagnosis and monitoring of diabetes with the use of breath analysis.

  • DUI or Diabetes? Taylor, Lawrence // Diabetes Health;Sep2006, Vol. 15 Issue 9, p45 

    The article focuses on the similarity in the symptoms of alcohol intoxication with low blood glucose level in diabetic patients. Diabetic patients are commonly and mistakenly arrested for drunk driving while they are not really under the influence of alcohol. Symptoms such as dizziness, slurred...

  • Does diabetes affect [[sup 18] F]FDG standardised uptake values in lung cancer? Gorenberg, Miguel; Hallett, William A.; O'Doherty, Michael J. // European Journal of Nuclear Medicine & Molecular Imaging;2002, Vol. 29 Issue 10, p1324 

    The correlation of hyperglycaemia with decreased 2-[[sup 18] F]fluoro-2-deoxy-D-glucose (FDG) uptake by tumours in positron emission tomography (PET) imaging has been clearly established. The available data are mainly based on non-diabetic (non-DM) patients exposed to acute hyperglycaemia after...

  • Motility and GI function studies billing and coding guidelines: a position paper of the American Motility Society. Botoman, V. Alin; Rao, Satish; Dunlap, Polly; Abell, Tom; Falk, Gary W. // American Journal of Gastroenterology;Jun2003, Vol. 98 Issue 6, p1228 

    Tests that measure gastrointestinal function, such as esophageal motility testing, ambulatory twenty-four hour pH, electrogastrography, gastroduodenal, sphincter of Oddi, and anorectal manometry, as well as hydrogen breath testing are now an essential part in the evaluation of patients with...

  • Association of Diabetes and HbA1c Levels With Gastrointestinal Manifestations. Ping-Huei Tseng; Yi-Chia Lee; Han-Mo Chiu; Chien-Chuan Chen; Wei-Chih Liao; Chia-Hung Tu; Wei-Shiung Yang; Ming-Shiang Wu // Diabetes Care;May2012, Vol. 35 Issue 5, p1053 

    OBJECTIVE--To determine the prevalence of gastrointestinal (GI) manifestations associated with diabetes mellitus (DM) in a Taiwanese population undergoing bidirectional endoscopies. RESEARCH DESIGN AND METHODS--Subjects voluntarily undergoing upper endoscopy/colonoscopy as part of a medical...

  • Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus Talley, Nicholas J.; Howell, Stuart; Jones, Michael P.; Horowitz, Michael // American Journal of Gastroenterology;Dec2002, Vol. 97 Issue 12, p3087 

    BACKGROUND:Both the natural history of GI symptoms and factors influencing symptom turnover in diabetes mellitus are unknown. We aimed to determine the natural history of GI symptoms in diabetes mellitus over a 3-yr period.METHODS:Subjects with predominantly Type 2 diabetes on the mailing list...

  • Can Symptoms Discriminate Among Those With Delayed or Normal Gastric Emptying in Dysmotility-Like Dyspepsia? Talley, Nicholas J.; Verlinden, Marleen; Jones, Michael // American Journal of Gastroenterology;May2001, Vol. 96 Issue 5, p1422 

    OBJECTIVE: Different subgroups can be identified in functional dyspepsia based on symptom type or severity, and may correlate with pathophysiological disturbances. In particular, female sex and severe fullness and vomiting have been reported to be strong independent predictors of slow solid...

  • Semi-quantitative assessment of cerebral blood flow with [sup 99m] Tc-HMPAO SPET in type I diabetic patients with no clinical history of cerebrovascular disease. Quirce, Remedios; Carril, José M.; Jiménez-Bonilla, Julio F.; Amado, José A.; Gutiérrez-Mendiguchía, Ceferino; Banzo, Ignacio; Blanco, Isabel; Uriarte, Isabel; Montero, Alfonso // European Journal of Nuclear Medicine;1997, Vol. 24 Issue 12, p1507 

    In 65 type I diabetic patients we prospectively evaluated brain perfusion by means of single-photon emission tomography after the injection of 7401110 MBq of technetium-99m hexamethylpropylene amine oxime. Thirty-five of the patients presented complications secondary to their diabetes. None...

  • PET scans 'affected by glucose therapy'.  // GP: General Practitioner;6/11/2010, p14 

    The article reveals that Diabetes treatment may affect the results of cancer screening test using positron emission tomography (PET) scans, as reported by a study conducted in the U.S.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics